Results 211 to 220 of about 5,541,707 (291)

Reduced Levels of Resolvin D1 and Thrombospondin-1 in Vernal Keratoconjunctivitis. [PDF]

open access: yesJ Clin Pract Res
Konuk ŞG   +5 more
europepmc   +1 more source

Classification of Seasonal Allergic Rhinitis Patients by Prospective Patient‐Recorded Symptoms: The @IT.2020 Project

open access: yesAllergy, EarlyView.
Daily prospective symptom reports from participants in this multicentre observational study were compared to retrospective (last 12 months) reports based on ARIA clinical questionnaire. Retrospective reports substantially underestimated, and to a lesser extent overestimated, symptom frequency compared to e‐Diary prospective reports. Since retrospective
Stephanie Dramburg   +56 more
wiley   +1 more source

Using Lotilaner Ophthalmic Solution, 0.25% to Treat <i>Demodex</i> Blepharitis in Patients Who Were Initially Misdiagnosed: A Case Series. [PDF]

open access: yesClin Optom (Auckl)
Periman LM   +14 more
europepmc   +1 more source

Parental and Healthcare Professional Experiences of Food Allergen Introduction During Complementary Feeding: A Behavioural Theory–Informed Systematic Review

open access: yesAllergy, EarlyView.
ABSTRACT Background IgE‐mediated food allergy burdens individuals, families and healthcare systems. Randomised controlled trials indicate early introduction and regular consumption of common food allergens in infancy can reduce food allergy risk. Few studies have explored parental and healthcare professional experiences. This systematic review examines
Karen Wright   +14 more
wiley   +1 more source

Pathophysiological and molecular insights into allergic conjunctivitis: an expanding analysis of immunological endotypes. [PDF]

open access: yesFront Allergy
Velazquez-Soto H   +5 more
europepmc   +1 more source

Efficacy and Safety of Intralymphatic Immunotherapy With Grass Allergoid and Microcrystalline Tyrosine: A Double‐Blind Randomised Placebo‐Controlled Trial

open access: yesAllergy, EarlyView.
This is the first randomised placebo‐controlled trial of intralymphatic immunotherapy using a microcrystalline tyrosine‐adjuvanted grass pollen allergoid. Three ultrasound‐guided ILIT injections were well tolerated and reduced combined symptom‐medication scores compared with placebo. The findings support further optimisation and clinical development of
Lara Šošić   +13 more
wiley   +1 more source

Distinction between allergic rhinitis alone and allergic rhinitis + asthma in MASK-air® real-world studies; a ARIA-WAO task force review. [PDF]

open access: yesWorld Allergy Organ J
Sousa-Pinto B   +31 more
europepmc   +1 more source

Updated EAACI Statement on Drug Hypersensitivity Skin Testing: Methodology and Non‐Irritative Concentrations

open access: yesAllergy, EarlyView.
ABSTRACT These updated EAACI guidelines aim to standardize skin testing methodologies for both immediate and non‐immediate drug hypersensitivity reactions. For immediate reactions, the optimal testing window is 4–6 weeks post‐reaction; whereas beyond 6 months, false‐negative results increase.
Annick Barbaud   +14 more
wiley   +1 more source

Influence of Environmental Pollution on Basophil Reactivity to Birch Pollen Allergens in Atopic and Non‐Atopic Subjects

open access: yesAllergy, EarlyView.
Birch pollen and PM10 are key determinants of clinical symptoms, particularly in asthma. Allergic people react stronger to the pollen collected in the highly polluted area than in the less polluted areas. When evaluating the effectiveness of allergen immunotherapy, it is essential to consider not only pollen concentrations but also levels of air ...
Maria Czarnobilska   +5 more
wiley   +1 more source

Comparative analysis of microbiota in the ocular surface of patients with atopic keratoconjunctivitis and Stevens-Johnson Syndrome with severe ocular complications. [PDF]

open access: yesFront Immunol
Ueta M   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy